Overview
Distinguish unconjugated transitional jaundice from cholestasis, identify pale stool and dark urine early and accelerate specialist investigation of biliary atresia while protecting nutrition and fat-soluble vitamins.
At the two-week check and every contact, ask whether jaundice persists and inspect the sclera and skin in good light, but do not estimate concentration visually. Establish gestation, feeding, weight, urine and stool colour, bruising, fever and newborn screening. Examine hydration, growth, liver, spleen, abdomen and dysmorphism. A photo of stool can help, but colour-card comparison and direct clinical action are preferable to verbal terms such as light brown.
NICE thresholds trigger investigation rather than diagnosis. In a term infant jaundiced beyond fourteen days, or preterm infant beyond twenty-one, look for pale stool and dark urine and measure fractionated bilirubin. Obtain FBC, maternal and infant groups and DAT, consider urine culture when infection is suspected and confirm metabolic screening including congenital hypothyroidism. Conjugated bilirubin over 25 micromol/L needs expert advice.
Aetiology
Biliary atresia
Progressive fibro-inflammatory obliteration of extrahepatic and intrahepatic bile ducts develops around birth and blocks bile drainage.
Infectious or metabolic cholestasis
Sepsis, UTI, galactosaemia, tyrosinaemia, alpha-1 antitrypsin deficiency and endocrine disease can all produce conjugated neonatal jaundice.
Structural obstruction
Choledochal cyst, inspissated bile and other anatomical lesions obstruct extrahepatic flow and may be visible on specialist ultrasound.
Unconjugated prolonged jaundice
Breast-milk jaundice, haemolysis, hypothyroidism and increased enterohepatic circulation usually raise unconjugated rather than direct serum bilirubin.
Pathophysiology
- 1Obstructed bile flow
Duct injury prevents conjugated bilirubin and bile acids entering intestine, producing dark urine and absent stool pigment.
- 2Fibrosis progression
Retained bile and inflammation rapidly scar portal tracts, leading to cirrhosis and portal hypertension if drainage is not restored.
- 3Fat malabsorption
Lack of intestinal bile impairs micelle formation and absorption of fat, energy and vitamins A, D, E and K.
- 4Coagulation vulnerability
Vitamin K malabsorption reduces clotting-factor activation, causing bruising or intracranial and gastrointestinal bleeding despite a well early appearance.
Clinical features and red flags
White, chalky, putty or very pale stool reflects absent intestinal bile pigment and requires urgent cholestasis assessment.
Water-soluble conjugated bilirubin passes into urine and stains the nappy, unlike isolated unconjugated breast-milk jaundice.
An infant with biliary atresia may feed and look comfortable initially despite ongoing duct destruction and fibrosis.
Hepatomegaly, raised direct bilirubin and GGT with poor growth support obstructed or hepatocellular bile flow.
Bruising, mucosal bleeding, melaena or neurological deterioration can reflect severe coagulopathy from fat-soluble vitamin malabsorption.
Investigations
- 01
First-line fractionated serum bilirubinFirst stepFirst line - Why
- Distinguish conjugated cholestasis from predominantly unconjugated prolonged jaundice.
- Interpretation and limitations
- Direct bilirubin above 25 micromol/L requires expert advice; any convincing pale stool accelerates referral.
- 02
NICE prolonged-jaundice screen - Why
- Assess FBC, blood groups, DAT, suspected UTI and completion of newborn metabolic screening.
- Interpretation and limitations
- These identify haemolysis, anaemia, infection and endocrine disease but do not replace direct bilirubin.
- 03
Specialist liver and coagulation profile - Why
- Assess hepatocellular injury, cholestasis, synthetic function, glucose and urgent vitamin-K-related bleeding risk.
- Interpretation and limitations
- INR that fails to correct appropriately raises synthetic failure concern and needs liver-centre management.
- 04
Expert hepatobiliary ultrasound - Why
- Assess gallbladder, ducts, liver, spleen, vessels and structural lesions such as choledochal cyst.
- Interpretation and limitations
- Supportive findings guide the pathway, but a reportedly normal scan cannot independently exclude biliary atresia.
Differential diagnosis
Breast milk jaundice
A thriving breastfed infant can have prolonged unconjugated bilirubin but should still pass pigmented stool and have non-staining urine.
Haemolysis
Anaemia, reticulocytosis, blood-group incompatibility or enzyme deficiency raises unconjugated bilirubin and produces a distinct laboratory pattern.
Neonatal hepatitis
Infectious, genetic and idiopathic hepatocellular disease can cause conjugated jaundice with hepatomegaly, pale stool and impaired growth.
Congenital hypothyroidism
Prolonged jaundice with feeding difficulty, hypotonia or constipation requires confirmation that newborn metabolic screening was completed.
Urinary infection
UTI may cause prolonged jaundice with nonspecific symptoms and requires a correctly collected culture when clinically suspected.
Management
01ScreenFractionate prolonged jaundiceFirst stepJaundice persists beyond the gestation-specific NICE threshold.+
- 1Inspect stool and urine and examine growth, liver, spleen and systemic state.
- 2Measure conjugated bilirubin, FBC, groups and DAT, assess UTI and confirm metabolic screening.
- 3Seek expert advice for direct bilirubin above twenty-five or immediately for pale stool or clinical deterioration.
02CholestasisAccelerate liver-centre diagnosisConjugated bilirubin is raised or stool and urine indicate obstructed bile flow.+
- 1Contact paediatric gastroenterology or the regional liver centre without sequential primary-care delay.
- 2Assess liver, coagulation, glucose, infectious, metabolic and nutritional status.
- 3Use expert ultrasound and specialist biopsy or cholangiography to distinguish biliary atresia from other causes.
Complications
Cirrhosis and portal hypertension
Continuing obstruction causes fibrosis, splenomegaly, ascites and variceal bleeding even after partially successful initial surgical drainage.
Fat-soluble vitamin deficiency
Vitamin K bleeding, vitamin D bone disease, vitamin A visual harm and vitamin E neurological injury can develop rapidly.
Growth failure
Fat malabsorption, increased metabolic need and feeding difficulty impair weight and length during a period of rapid growth.
Liver transplantation
Failed bile drainage or progressive cirrhosis may require liver transplantation despite timely Kasai portoenterostomy and specialist medical care.
Monitoring and follow-up
- Review stool colour, urine staining, bilirubin and liver profile through the specialist plan.
- Plot weight and length frequently and adjust energy and fat formulation with paediatric dietetics.
- Monitor INR and measured vitamins A, D and E and replace through liver-centre regimens.
- After Kasai, assess fever and pale stool urgently for ascending cholangitis or loss of drainage.
- Track spleen size, platelets, ascites and gastrointestinal bleeding for portal hypertension.
- Coordinate vaccination, transplant assessment and family psychosocial support as disease evolves.
Special situations
Stool colour beats apparent wellness
Visible acholic stool can reveal biliary atresia before growth, behaviour or liver synthetic function deteriorates.
Direct bilirubin changes the pathway
Breast-milk jaundice is unconjugated, so a raised conjugated fraction cannot be dismissed because breastfeeding is going well.
Ultrasound is not an exclusion test
Biliary atresia may lack a single definitive sonographic sign and needs specialist integrated diagnosis.
Kasai is time sensitive
Progressive fibrosis means referral speed matters even though surgery timing is decided by the liver centre.
Common pitfalls
- 01
Calling persistent jaundice breast-milk jaundice without measuring the conjugated fraction.
- 02
Asking only whether stool is yellow rather than checking for pale chalky colour.
- 03
Waiting for a sick appearance before referring cholestasis.
- 04
Using normal ultrasound to exclude biliary atresia.
- 05
Forgetting coagulation and vitamin K risk.
- 06
Delaying referral while repeating bilirubin in routine primary care.